Real-time enrollment status for this lewy body dementia clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 12:07 AM UTC
| NCT Number | NCT07029581 |
| Recruiting Status | Recruiting |
| Condition | Lewy Body Dementia |
| Phase | PHASE2 |
| Target Enrollment | 180 participants |
| Active Locations | 30 sites in the US |
| Sponsor | ACADIA Pharmaceuticals Inc. |
| Last Updated on CT.gov | September 29, 2026 (2 weeks ago) |
As of October 18, 2026: Clinical trial NCT07029581 is currently recruiting participants. This phase2 study for lewy body dementia is actively seeking new participants at 30 locations across the United States. The study is sponsored by ACADIA Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07029581 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07029581 was last updated 2 weeks ago (September 29, 2026). HelloStudys verifies this status automatically.